Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The price of Oncology Institute Inc (NASDAQ: TOI) closed at $3.20 in the last session, down -1.54% from day before closing price of $3.25. In other words, the price has decreased by -$1.54 from its previous closing price. On the day, 6.11 million shares were traded.
Ratios:
We take a closer look at TOI’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.59 and its Current Ratio is at 1.79. In the meantime, Its Debt-to-Equity ratio is 20.18 whereas as Long-Term Debt/Eq ratio is at 18.83.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on May 15, 2025, initiated with a Buy rating and assigned the stock a target price of $7.
On September 14, 2022, Guggenheim started tracking the stock assigning a Buy rating and target price of $7.Guggenheim initiated its Buy rating on September 14, 2022, with a $7 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 03 ’25 when BRADFORD DANIEL HIVELY bought 39,600 shares for $2.87 per share.
BRADFORD DANIEL HIVELY bought 1,936,537 shares of TOI for $5,557,861 on Jun 03 ’25. On May 20 ’25, another insider, M33 Growth I L.P., who serves as the Director of the company, sold 1,796,468 shares for $2.71 each. As a result, the insider received 4,873,638 and left with 14,624,233 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.71 while its Price-to-Book (P/B) ratio in mrq is 56.14.
Stock Price History:
Over the past 52 weeks, TOI has reached a high of $3.50, while it has fallen to a 52-week low of $0.13. The 50-Day Moving Average of the stock is 36.44%, while the 200-Day Moving Average is calculated to be 248.61%.
Shares Statistics:
A total of 88.93M shares are outstanding, with a floating share count of 38.73M. Insiders hold about 56.57% of the company’s shares, while institutions hold 15.18% stake in the company.
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
Revenue Estimates
According to 1 analysts, the current quarter’s revenue is expected to be $112.56M. It ranges from a high estimate of $112.56M to a low estimate of $112.56M. As of the current estimate, Oncology Institute Inc’s year-ago sales were $98.58MFor the next quarter, 1 analysts are estimating revenue of $119.49M. There is a high estimate of $119.49M for the next quarter, whereas the lowest estimate is $119.49M.
Based on 1 analysts’ estimates, the company’s revenue will be $536.33M in the next fiscal year. The high estimate is $536.33M and the low estimate is $536.33M.
